NHS National Framework Agreement for Omalizumab

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£87M
Sector
MISCELLANEOUS
Published
30 Dec 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 3 suppliers

1 buyer

3 suppliers

Description

Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Award Detail

1 Celltrion Healthcare (Uxbridge)
  • Lot 1 - CM/TNS/25/5734
  • Reference: 2
  • Value: £87,433,000 [share]
  • Awarded to group of suppliers.
2 Mercury Pharmaceuticals (London)
  • Lot 1 - CM/TNS/25/5734
  • Reference: 2
  • Value: £87,433,000 [share]
  • Awarded to group of suppliers.
3 Novartis Pharmaceuticals (London)
  • Lot 1 - CM/TNS/25/5734
  • Reference: 2
  • Value: £87,433,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-058e04
  • FTS 086501-2025

Domains